These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 22268103

  • 1. Cinaciguat, a novel activator of soluble guanylate cyclase, protects against ischemia/reperfusion injury: role of hydrogen sulfide.
    Salloum FN, Das A, Samidurai A, Hoke NN, Chau VQ, Ockaili RA, Stasch JP, Kukreja RC.
    Am J Physiol Heart Circ Physiol; 2012 Mar 15; 302(6):H1347-54. PubMed ID: 22268103
    [Abstract] [Full Text] [Related]

  • 2. NO-independent stimulation or activation of soluble guanylyl cyclase during early reperfusion limits infarct size.
    Bice JS, Keim Y, Stasch JP, Baxter GF.
    Cardiovasc Res; 2014 Feb 01; 101(2):220-8. PubMed ID: 24259501
    [Abstract] [Full Text] [Related]

  • 3. Preconditioning with soluble guanylate cyclase activation prevents postischemic inflammation and reduces nitrate tolerance in heme oxygenase-1 knockout mice.
    Wang WZ, Jones AW, Wang M, Durante W, Korthuis RJ.
    Am J Physiol Heart Circ Physiol; 2013 Aug 15; 305(4):H521-32. PubMed ID: 23771693
    [Abstract] [Full Text] [Related]

  • 4. Pharmacological activation of soluble guanylate cyclase protects the heart against ischemic injury.
    Korkmaz S, Radovits T, Barnucz E, Hirschberg K, Neugebauer P, Loganathan S, Veres G, Páli S, Seidel B, Zöllner S, Karck M, Szabó G.
    Circulation; 2009 Aug 25; 120(8):677-86. PubMed ID: 19667237
    [Abstract] [Full Text] [Related]

  • 5. Pre-conditioning with the soluble guanylate cyclase activator Cinaciguat reduces ischaemia-reperfusion injury after cardiopulmonary bypass.
    Radovits T, Korkmaz S, Miesel-Gröschel C, Seidel B, Stasch JP, Merkely B, Karck M, Szabó G.
    Eur J Cardiothorac Surg; 2011 Feb 25; 39(2):248-55. PubMed ID: 20591683
    [Abstract] [Full Text] [Related]

  • 6. Phosphodiesterase-5 inhibitor, tadalafil, protects against myocardial ischemia/reperfusion through protein-kinase g-dependent generation of hydrogen sulfide.
    Salloum FN, Chau VQ, Hoke NN, Abbate A, Varma A, Ockaili RA, Toldo S, Kukreja RC.
    Circulation; 2009 Sep 15; 120(11 Suppl):S31-6. PubMed ID: 19752383
    [Abstract] [Full Text] [Related]

  • 7. Effects of soluble guanylate cyclase activation on heart transplantation in a rat model.
    Loganathan S, Korkmaz-Icöz S, Radovits T, Li S, Mikles B, Barnucz E, Hirschberg K, Karck M, Szabó G.
    J Heart Lung Transplant; 2015 Oct 15; 34(10):1346-53. PubMed ID: 26210750
    [Abstract] [Full Text] [Related]

  • 8. Cardioprotection by ischemic postconditioning and cyclic guanosine monophosphate-elevating agents involves cardiomyocyte nitric oxide-sensitive guanylyl cyclase.
    Frankenreiter S, Groneberg D, Kuret A, Krieg T, Ruth P, Friebe A, Lukowski R.
    Cardiovasc Res; 2018 May 01; 114(6):822-829. PubMed ID: 29438488
    [Abstract] [Full Text] [Related]

  • 9. Cardioprotective PKG-independent NO signaling at reperfusion.
    Cohen MV, Yang XM, Liu Y, Solenkova NV, Downey JM.
    Am J Physiol Heart Circ Physiol; 2010 Dec 01; 299(6):H2028-36. PubMed ID: 20852051
    [Abstract] [Full Text] [Related]

  • 10. The soluble guanylate cyclase stimulator riociguat and the soluble guanylate cyclase activator cinaciguat exert no direct effects on contractility and relaxation of cardiac myocytes from normal rats.
    Reinke Y, Gross S, Eckerle LG, Hertrich I, Busch M, Busch R, Riad A, Rauch BH, Stasch JP, Dörr M, Felix SB.
    Eur J Pharmacol; 2015 Nov 15; 767():1-9. PubMed ID: 26407652
    [Abstract] [Full Text] [Related]

  • 11. Cinaciguat, a soluble guanylate cyclase activator, augments cGMP after oxidative stress and causes pulmonary vasodilation in neonatal pulmonary hypertension.
    Chester M, Seedorf G, Tourneux P, Gien J, Tseng N, Grover T, Wright J, Stasch JP, Abman SH.
    Am J Physiol Lung Cell Mol Physiol; 2011 Nov 15; 301(5):L755-64. PubMed ID: 21856817
    [Abstract] [Full Text] [Related]

  • 12. Hydrogen sulfide mediates the cardioprotective effects of gene therapy with PKG-Iα.
    Das A, Samidurai A, Hoke NN, Kukreja RC, Salloum FN.
    Basic Res Cardiol; 2015 Nov 15; 110(4):42. PubMed ID: 26036467
    [Abstract] [Full Text] [Related]

  • 13. Cardioprotective effects of PKG activation by soluble GC activator, BAY 60-2770, in ischemia-reperfusion-injured rat hearts.
    Lee KH, Lee SR, Cho H, Woo JS, Kang JH, Jeong YM, Cheng XW, Kim WS, Kim W.
    PLoS One; 2017 Nov 15; 12(7):e0180207. PubMed ID: 28671970
    [Abstract] [Full Text] [Related]

  • 14. Cinaciguat, a soluble guanylate cyclase activator, causes potent and sustained pulmonary vasodilation in the ovine fetus.
    Chester M, Tourneux P, Seedorf G, Grover TR, Gien J, Abman SH.
    Am J Physiol Lung Cell Mol Physiol; 2009 Aug 15; 297(2):L318-25. PubMed ID: 19465519
    [Abstract] [Full Text] [Related]

  • 15. Pharmacological stimulation of soluble guanylate cyclase modulates hypoxia-inducible factor-1alpha in rat heart.
    Tsuruda T, Hatakeyama K, Masuyama H, Sekita Y, Imamura T, Asada Y, Kitamura K.
    Am J Physiol Heart Circ Physiol; 2009 Oct 15; 297(4):H1274-80. PubMed ID: 19684186
    [Abstract] [Full Text] [Related]

  • 16. Cardioprotection by H2S engages a cGMP-dependent protein kinase G/phospholamban pathway.
    Bibli SI, Andreadou I, Chatzianastasiou A, Tzimas C, Sanoudou D, Kranias E, Brouckaert P, Coletta C, Szabo C, Kremastinos DT, Iliodromitis EK, Papapetropoulos A.
    Cardiovasc Res; 2015 Jun 01; 106(3):432-42. PubMed ID: 25870184
    [Abstract] [Full Text] [Related]

  • 17. Soluble guanylyl cyclase activation improves progressive cardiac remodeling and failure after myocardial infarction. Cardioprotection over ACE inhibition.
    Fraccarollo D, Galuppo P, Motschenbacher S, Ruetten H, Schäfer A, Bauersachs J.
    Basic Res Cardiol; 2014 Jul 01; 109(4):421. PubMed ID: 24907870
    [Abstract] [Full Text] [Related]

  • 18. Pressure-overload-induced subcellular relocalization/oxidation of soluble guanylyl cyclase in the heart modulates enzyme stimulation.
    Tsai EJ, Liu Y, Koitabashi N, Bedja D, Danner T, Jasmin JF, Lisanti MP, Friebe A, Takimoto E, Kass DA.
    Circ Res; 2012 Jan 20; 110(2):295-303. PubMed ID: 22095726
    [Abstract] [Full Text] [Related]

  • 19. Stimulation of cGMP signalling protects coronary endothelium against reperfusion-induced intercellular gap formation.
    Kasseckert SA, Schäfer C, Kluger A, Gligorievski D, Tillmann J, Schlüter KD, Noll T, Sauer H, Piper HM, Abdallah Y.
    Cardiovasc Res; 2009 Jul 15; 83(2):381-7. PubMed ID: 19234300
    [Abstract] [Full Text] [Related]

  • 20. Feedback control through cGMP-dependent protein kinase contributes to differential regulation and compartmentation of cGMP in rat cardiac myocytes.
    Castro LR, Schittl J, Fischmeister R.
    Circ Res; 2010 Nov 12; 107(10):1232-40. PubMed ID: 20847310
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.